Susan Kalled

Insider

First SEC filing: May 5, 2021 · Latest: May 5, 2021

On this page

Insider at

0 buys (P) 0 sells (S) Net: $0 + 3 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
Feb. 18, 2022	CMPX	A	60,000	—	—	60,000 Direct	—	Acquired	(price as of 2026-08-20)
Feb. 17, 2022	CMPX	A	60,000	—	—	60,000 Direct	—	Acquired	(price as of 2026-08-20)
May 3, 2021	CMPX	A	260,000	—	—	260,000 Direct	—	Acquired	(price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
Feb. 18, 2022	CMPX	Stock Option (Right to Buy)	Common Stock (60,000)	$2.40	Feb. 17, 2032	60,000	Acquired
Feb. 17, 2022	CMPX	Stock Option (Right to Buy)	Common Stock (60,000)	$2.52	Feb. 16, 2032	60,000	Acquired
May 3, 2021	CMPX	Stock Option (Right to Buy)	Common Stock (260,000)	$7.00	May 3, 2031	260,000	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Matched by name from proxy statements (DEF 14A) — verify against the filing.

Ph.D.(2) Chief Scientific Officer

Fiscal year	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension change	Other	Total
2022	$297,500	—	—	—	—	—	$54,333	$462,030
2021	$220,000	$115,500	—	$1,446,116	—	—	—	$1,781,616

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.